Precision Medicine in Oncology: Personalized Approaches for Diagnosis, Treatment, and Prognosis
Main Article Content
Abstract
Precision medicine has emerged as a transformative approach in oncology, offering personalized strategies for cancer diagnosis, treatment, and prognosis. This paper provides a comprehensive overview of precision medicine's role in oncology, focusing on genomic profiling, targeted therapies, immunotherapy, liquid biopsies, and personalized monitoring. By analyzing the genetic and molecular characteristics of individual tumors, precision medicine enables the identification of specific mutations and biomarkers that drive cancer progression. This knowledge facilitates the selection of targeted therapies tailored to each patient's unique tumor biology, improving treatment efficacy while minimizing adverse effects. Additionally, immunotherapy harnesses the body's immune system to target cancer cells, with biomarkers guiding patient selection and predicting treatment response. Liquid biopsies offer a non-invasive method for detecting circulating tumor DNA and monitoring treatment response over time.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Shaw AT, Hsu PP, Awad MM, et al. Tyrosine kinase gene rearrangements in epithelial malignancies. Nat Rev Cancer. 2013;13(11):772-787.
Prahallad A, Sun C, Huang S, et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 2012;483(7388):100-103.
Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443-2454.
Le DT, Uram JN, Wang H, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015;372(26):2509-2520.
Tie J, Wang Y, Tomasetti C, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8(346):346ra92.
Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531-548.
Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793-795.
Schilsky RL. Implementing personalized cancer care. Nat Rev Clin Oncol. 2014;11(7):432-438.
Rodon J, Soria JC, Berger R, et al. Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial. Ann Oncol. 2015;26(9):1791-1798.
Collins FS, Hamburg MA. First FDA authorization for next-generation sequencer. N Engl J Med. 2013;369(25):2369-2371.